Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study.
Georgia-Savina MoysidouPanagiotis GarantziotisDionysis S NikolopoulosPelagia KatsimbriAntonis FanouriakisDimitrios T BoumpasPublished in: Lupus (2022)
Severe hematologic disease in SLE has a high risk of relapse, which may be mitigated by the early institution of GC-sparing agents.